As of Feb 27
| -0.23 / -0.42%|
The 3 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 58.00, with a high estimate of 60.00 and a low estimate of 55.00. The median estimate represents a +5.99% increase from the last price of 54.72.
The current consensus among 3 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.